Generics 26

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Rivastigmine manufacturers

26 products found

Filters

26 products found

rivastigmine

Oral solution 50 mg/120 ml , 2 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Greece
Available for
Licensing with supply, Distribution only
Manufacturer #271
A pharmaceutical manufacturer based in the EU that is active in 30+ countries selling its products in Europe, Africa, the Middle East, and Asia for 50+ years. The company's production lines are EU GMP-compliant. Key production lines are Rx, OTC, nutraceuticals, infant nutrition, and cosmetics. Main therapeutic areas include dermatology, antibiotics, and oncology.

Manufacturer usually replies in 9 days

rivastigmine

Capsules 1.5 mg, 3 mg, 4.5 mg, 6 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Greece
Available for
Licensing with supply, Distribution only
Manufacturer #271
A pharmaceutical manufacturer based in the EU that is active in 30+ countries selling its products in Europe, Africa, the Middle East, and Asia for 50+ years. The company's production lines are EU GMP-compliant. Key production lines are Rx, OTC, nutraceuticals, infant nutrition, and cosmetics. Main therapeutic areas include dermatology, antibiotics, and oncology.

Manufacturer usually replies in 9 days

rivastigmine

Oral solution 2 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Registered in
Greece
Manufacturer #17290
A pharmaceutical manufacturer based in the EU that is active in Europe, Africa, and Asia for 100+ years. Key production lines are pharmaceuticals, food supplements, OTC, and cosmetics. The main therapeutic areas include dermatology, respiratory system, and antibiotic.

Manufacturer usually replies in 4 days

rivastigmine

Oral solution 2 mg/ml - 120 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #313

A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, and Asia for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. Main therapeutic areas include the respiratory system, dermatology, and cardiovascular system. The company possesses several branches in LATAM

Manufacturer usually replies in 7 days

rivastigmine

Capsules 1.5 mg, 3 mg, 4.5 mg, 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply
Manufacturer #8588
It was founded in the early 1990s. It is in South-Eastern Europe. Customer satisfaction is the main priority and provides a wide range of medicines, herbal medicines, and biologically active products. The company is present in a foreign market with more than 20% of the product portfolio.

Manufacturer usually replies in 9 days

rivastigmine

Capsules 1.5 mg, 3 mg, 4.5 mg, 6 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

rivastigmine

Oral solution 2 mg/mL

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #16299
The company has a manufacturer’s license for medicinal products for human use authorized by the National Agency of Medicines. The highest quality products are manufactured and packaged in the production units with GMP International Standards and regularly checked by the National Agency of Medicines by the requirements of the European Medicines Agency (EMEA). The principal activity of the company is the production of pharmaceutical products, which are certified with patents, in various forms (tablets, capsules, syrups, oral solutions, powders for liquid compositions, gels, creams, and ointments) and various categories (antibiotics, antifungals, antivirals, anti-inflammatories, analgesics, antipyretics, anxiolytics, antidepressants, bronchodilators, antilipidemics, antitussives, cholinesterase inhibitors, antipsoriatics, antacids, anticholinergics, antidiarrheals, etc.).

Manufacturer usually replies in 15 days

rivastigmine

Oral solution 2mg/ml - 120ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply
Manufacturer #15932

A pharmaceutical manufacturer based in the EU that is active in 20+ countries for 20+ years. Key production lines are generic, medical device, OTC, nutraceuticals, and cosmetics. They are produced in GMP-compliant manufacture. Main therapeutic areas include allergology and pulmonology, cardiology, dermatology, and the central nervous system. The main dosage forms are liquid, solid, semi-solid, and sprays.

Manufacturer usually replies in 11 days

rivastigmine

Oral solution 2 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Lactose free, Sugar free, Alcohol free
Manufacturer #1969
A pharmaceutical manufacturer based in the EU that has been active in 20+ countries selling its products in Europe, the Middle East, LATAM, Africa, and Asia for 80+ years. The company's production lines are GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and respiratory system. Main dosage forms include oral solid, oral liquid, and semi-solid forms.

Manufacturer usually replies in 22 days

rivastigmine

Oral solution 2mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #623

Manufacturer usually replies in 9 days

rivastigmine

Capsules 1,5mg, 3mg, 4,5mg, 6mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #623

Manufacturer usually replies in 9 days

rivastigmine

Tablets 1.5mg, 3mg, 4.5mg, 6mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
New Zealand
GMP approvals
EU GMP
Unavailable markets
Vietnam , Thailand , Malaysia , Singapore , Hong Kong , Australia , United States , Saudi Arabia , Kuwait , United Arab Emirates , Oman , Qatar , Bahrain
Manufacturer #12087
It is one of the largest privately-held pharmaceutical corporations in the world. They are tireless in their pursuit of improving healthcare outcomes for individuals all across the world. Every day, nearly 770 individuals collaborate, innovate, and grow with a firm that prioritizes people and encourages, develops, and challenges them to do their best job.

Manufacturer usually replies in 6 days

rivastigmine

Patch 4.6 mg, 13.3 mg, 9.5 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Comments
Ref : Exelon (Novartis) STRENGTH : 4.6mg/24hr, 9.5mg/24hr, 13.3mg/24hr
Manufacturer #1338

Manufacturer usually replies in 7 days

rivastigmine

Capsules 1.5 mg, 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21084

Manufacturer usually replies in 5 days

rivastigmine

Patch 4.6; 9.5 and 13.3 mg/24 h

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #13680
A pharmaceutical manufacturer based in LATAM that has been active for 30+ years. The main dosage forms are topical and transdermal pharmaceuticals. The main therapeutic areas include pain management and Alzheimer's disease. The company's production lines are cGMP-compliant.

Manufacturer usually replies in 5 days

rivastigmine

Tablets 15 mg, 3 mg, 4.5 mg, 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan, Yemen, Iraq
Manufacturer #20752
It is a pharmaceutical manufacturing company that was founded in Palestine 50 years ago. As an industry pioneer, it sought to address the shortages in medicinal products’ supplies as well as the untapped pharma innovation gap in Palestine. The core business is the development, manufacturing, and marketing of pharmaceutical products. To complement its medicinal products portfolio, the company has recently established partnerships with leading medical device and pharmaceutical manufacturers, thereby strengthening both the portfolios for medical devices and pharmaceutical medicines in Palestine and the region. In addition, they also produce detergent, cosmetics, personal hygiene, veterinary and agricultural products.

Manufacturer usually replies in 6 days

rivastigmine

Patch 4.6mg/24h, 9.5mg/24h, 13.3mg/24h

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #10242

Manufacturer usually replies in 9 days

rivastigmine

Capsules 3mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #438
It is one of the leading pharmaceutical companies in East Asia. It has a strong hold on respiratory and cardiovascular diseases. They are accumulating core technology to develop new world-class medicine and fostering key manpower that can develop and market new products.

Manufacturer usually replies in 6 days

rivastigmine

Oral solution 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan, EU GMP
Manufacturer #20767
It is a multinational pharmaceutical company specializing in the development, production, and distribution of generic and specialty medicines. They have a broad technology base covering OSD, liquids, creams, ointments, and sterile (injectable) across all key therapeutic areas. They have a further 90+ products (INNs) under development and registration. They aim to improve the quality of life by increasing access to high-quality and affordable medicines.

Manufacturer usually replies in 11 days

rivastigmine

Capsules 1.5 mg, 4.5 mg, 3 mg, 6 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan, EU GMP
Manufacturer #20767
It is a multinational pharmaceutical company specializing in the development, production, and distribution of generic and specialty medicines. They have a broad technology base covering OSD, liquids, creams, ointments, and sterile (injectable) across all key therapeutic areas. They have a further 90+ products (INNs) under development and registration. They aim to improve the quality of life by increasing access to high-quality and affordable medicines.

Manufacturer usually replies in 11 days

Want to view all 26 products? Create your free account today!

Rivastigmine manufacturers

Rivastigmine is a cholinesterase inhibitor which is used to treat Alzheimer's and Parkinson's disease in those who have mild to moderate symptoms. The medication can be taken orally or through a transdermal patch, which decreases the likelihood of adverse effects like nausea and vomiting. It belongs to the cholinesterase inhibitor class of drugs. It increases the number of a certain natural material in the brain, which improves mental function (such as memory and thinking).

How does Rivastigmine work?

This substance is a carbamate compound similar to physostigmine but its not donepezil or tacrine in structure. The exact mechanism of rivastigmine is unknown, however it is thought that It binds reversibly to and inactivates chlolinesterase (e.g., acetylcholinesterase, butyrylcholinesterase), limiting acetycholine hydrolysis and thereby increasing acetylcholine content at cholinergic synapses. When compared to acetylcholinesterase and butyrylcholinesterase in peripheral tissues, It's anticholinesterase activity is relatively selective for brain acetylcholinesterase and butyrylcholinesterase. Exelon, Exelon Patch are the brand names for this medication. Rivastigmine is the generic name. It is available as a capsule and a solution (liquid) for oral use. It is commonly taken twice a day, once in the evening and once in the morning after meals. The liquid medicine can be given straight from the injection or mixed with a little cup of water. Clean the outside of the syringe with a clean tissue after each use, then replace it in its plastic shell. Use a child-resistant closure to close the drug bottle..

Pricing of Rivastigmine

Based on the drugstore you visit, rivastigmine oral capsule 1.5 mg costs roughly $39 for a supply of 60 capsules. Prices are only valid for cash paying consumers and do not apply to insurance programmes. Despite the fact that local pricing are thought to be much lower than in the US.

Sourcing Rivastigmine Manufacturers and Suppliers

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Rivastigmine offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Rivastigmine. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Rivastigmine is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over this medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Rivastigmine manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.